Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer

Cancer Research

Volumn 57, Issue 8, 1997, Pages 1597-1604

  Kuukasjärvi, Tuula ^a,c   Karhu, Ritva ^a   Tanner, Minna ^a   Kähkönen, Marketta ^a   Schäffen, Alejandro ^b   Nupponen, Nina ^a   Pennanen, Sari ^a   Kallioniemi, Anne ^a,b   Kallioniemi, Olli Pekka ^a,b   Isola, Jorma ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GROWTH; CLINICAL PROTOCOL; CLONE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC HETEROGENEITY; GENOME; HUMAN; HUMAN TISSUE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; X CHROMOSOME INACTIVATION;

ADENOCARCINOMA; ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CARCINOMA, MEDULLARY; CHROMOSOME ABERRATIONS; DOSAGE COMPENSATION, GENETIC; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; MIDDLE AGED; NEOPLASM METASTASIS;

EID: 0342887306     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Fearon, E. R., and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell, 61: 759-767, 1990.
2. Bishop, J. M. The molecular genetics of cancer. Science (Washington DC), 235: 305-311, 1987.
3. Knudson, A. G. Antioncogenes and human cancer, Proc. Natl. Acad. Sci. USA, 90: 10914-10921, 1993.
4. Wooster, R., Neuhausen, S. L., Mangion, J., Quirk, Y., Ford, D., Collins, N., Nguyen, K., Seal, S., Tran, T., Averill, D., Fields, P., Marshall, G., Narod, S., Lenoir, G. M., Lynch, H., Feunteun, J., Devilee, P., Cornelisse, C. J., Menko, F. H., Daly, P. A., Qrmiston, W., McManus, R., Pye, C., Lewis, C. M., Cannon-Albright, L. A., Peto, J., Ponder, B. A. J., Skolnick, M. H., Easton, D. F., Goldgar, D. E., and Stratton, M. R. Localization of a breast cancer suspectibility gene, BRCA2, to chromosome 13q12- 13. Science (Washington DC), 265: 2088-2090, 1994.
5. Fidler, I. J., and Kripke, M. L. Metastasis results from preexisting variant cells within a malignant tumor. Science (Washington DC), 197: 893-895, 1977.
6. Turpeenniemi-Hujanen, T., Thorgeirsson, U. P., Hart, I. R., Grant, S. S., and Liotta, L. A. Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastatic potential. J. Natl. Cancer Inst., 75: 99-103, 1985.
7. Alvarez, O. A., Carmichael, D. F., and DeClerck, Y. A. Inhibition of collagenase activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metailoproteases. J. Natl. Cancer Inst., 82: 589-595, 1990.
8. Chambers, A. F. Ras-responsive genes and tumor metastasis. Crit. Rev. Oncog., 4: 95-114, 1993.
9. Steeg, P. S., Cohn, K. H., and Leone, A. Tumor metastasis and nm23: current concepts. Cancer Cells, 3: 257-262, 1991.
10. Duffy, M. J. The role of proteolytic enzymes in cancer invasion and metastasis. Clin. Exp. Metastasis, 70: 145-155, 1992.
11. Steeg, P. S. Invasion and metastasis. Curr. Opin. Oncol., 4: 134-141, 1992.
12. Duffy, M. J., O'Grady, P., Devaney, D., O'Siorain, L., Fennelly, J. J., and Lijnen, H. J. Urokinase-plasminogen activator, a marker for aggressive breast carcinoma. Cancer (Phila.), 62: 531-533, 1988.
13. Spyratos, F., Brouillet, J-P., Defrenne, A., Hacene, K., Rouesse, J., Maudelonde, T., Brunet, M., Andrieu, C., Despiaces, A., and Rochefort, H. Cathepsin D: an independent prognostic factor for metastasis of breast cancer. Lancet, 11: 1115-1118, 1989.
14. Tandon, A. K., Clark, G. M., Chamness, G. S., Chirgwin, J. M., and McGuire, W. L. Cathepsin D and prognosis of breast cancer. N. Engl. J. Med., 322: 297-302, 1990.
15. Chen, L. C., Kurisu, W., Ljung, B-M., Goldman, E. S., Moore, D., II, and Smith, H. S. Heterogeneity for allelic loss in human breast cancer, J. Natl. Cancer Inst., 84: 506-510, 1992.
16. Trent, J., Yang, J-M., Emerson, J., Dalton, W., McGee, D., Massey, K., Thompson, F., and Villar, H. Clonal chromosome abnormalities in human breast carcinoma II. Thirty-four cases with metastatic disease. Genes Chromosomes & Cancer, 7: 194- 203, 1993.
17. Teixeira, M. R., Teixeira, M. R., Bardi, G., Andersen, J. A., Mitelman, F., and Heim, S. Clonal heterogeneity in breast cancer: karyotypic comparisons of multiple intraand extra-tumorous samples from 3 patients. Int. J. Cancer, 63: 63-68, 1995.
18. Teixeira, M. R., Bardi, G., Andersen, J. A., and Heim, S. Karyotypic comparisons of multiple tumorous and macroscopically normal surruunding tissue samples from patients with breast cancer. Cancer Res., 56: 855-859, 1996.
19. Pandis, N., Jin, Y., Gorunova, L., Petersson, C., Bardi, G., Idvall, I., Johansson, B., Ingvar, C., Mandahl, N., Mitelman, F., and Heim, S. Chromosome analysis of 97 primary breast carcinomas: identification of eight karyotypic subgroups. Genes Chromosomes & Cancer, 12: 173-185, 1995.
20. Isola, J., DeVries, S., Chu, L. W., Ghazvini, S., and Waldman, F. Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples. Am. J. Pathol., 145: 1301-1308, 1994.
21. Kallioniemi, O-P., Kallioniemi, A., Piper, J., Waldman, F. M., Gray, J. W., and Pinkel, D. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes & Cancer, 10: 231-243, 1994.
22. Muleris, M., Almelda, A., Gerbault-Seureau, M., Malfoy, B., and Dutrillaux, B. Detection of DNA amplification in 17 primary breast carcinomas with homogeneously staining regions by a modified comparative genomic hybridization technique. Genes Chromosomes & Cancer, 10: 160-170, 1994.
23. Ried, T., Just, K. E., Holtgreve-Grez, H., du Manoir, S., Speicher, M. R., Schröck, E., Latham, E., Biegen, H., Zetterberg, A., Cremer, T., and Auer, G. Comparative genomic hybridization of formalin-fixed, paraffin-embedded breast carcinomas reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas. Cancer Res., 55: 5415-5423, 1995.
24. Ried, T., Knutzen, R., Steinbeck, R., Biegen, H., Schröck, E., Hesselmeyer, K., du Manoir, S., and Auer, G. Comparative genomic hybridization reveals a specific patterns of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes & Cancer, 15: 234-245, 1996.
25. Hartmann, W. H., Ozzello, L., Sobin, L. H., and Stalsberg, H. (eds.). Histological Typing of Breast Tumors, Ed 2. Geneva: WHO, 1981.
26. Telenius, H., Carter, N. P., Bebb, C. E., Nordenskjöld, M., Ponder, B. A. J., and Tunnacliffe, A. Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. Genomics, 13: 718-725, 1992.
27. Kuukasjärvi, T., Tanner, M., Pennanen, S., Karhu, R., Visakorpi, T., and Isola, J. Optimizing DOP-PCR for universal amplification of small DNA samples in comparative genomic hybridization. Genes Chromosomes & Cancer, 18: 94-101, 1997.
28. Piper, J., Rutovitz, D., Sudar, D., Kallioniemi, A., Kallioniemi, O-P., Waldman, F., Gray, J., and Pinkel, D. Computer image analysis of comparative genomic hybridization. Cytometry, 19: 10-26, 1995.
29. Gilliland, D. G., Blanchard, K. L., Levy, J., Perrin, S., and Bunn, F. Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction. Proc. Natl. Acad. Sci. USA, 88: 6848-6852, 1991.
30. Noguchi, S., Motomura, K., Inaji H., Imaoka, S., and Koyama, H. Clonal analysis of human breast cancer by means of the polymerase chain reaction. Cancer Res., 52: 6594-6597, 1992.
31. Hyytinen, E., Visakorpi, T., Kallioniemi, A., Kallioniemi, O-P., and Isola, J. Improved technique for analysis of formal in-fixed, paraffin-embedded tumors by fluorescence in situ hybridization. Cytometry, 16: 93-99, 1994.
32. Tanner, M., Tirkkonen, M., Kallioniemi, A., Collins, C., Stokke, T., Karhu, R., Kowbel, D., Shadrawan, F., Hintz, M., Kuo, W-L., Waldman, F., Isola, J., and Kallioniemi, O-P. Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes. Cancer Res., 54: 2457-2460, 1994.
33. Nowell, P. C. The clonal evolution of tumor cell populations. Science (Washington DC), 194: 23-28, 1976.
34. Fialkow, P. J. Clonal origin of human tumors. Biochim. Biophys. Acta, 458: 283-321, 1976.
35. Sidransky, D., Frost, P., Von Eschenbach, A., Qyasu, R., Preisinger, A. C., and Vogelstein, B. Clonal origin of bladder cancer. N. Engl. J. Med., 326: 737-740, 1992.
36. Tlsty, T. D., Briot, A., Gualberto, A., Hall, I., Hess, S., Hixon, M., Kuppuswamy, D., Romanov, S., Sage, M., and White, A. Genomic instability and cancer. Mutat. Res., 337: 1-7, 1995.
37. Boland, C. R., Sato, J., Appelman, H. D., Bresalier, R. S., and Feinberg, A. P. Microallelotyping defines the sequence and tempo of allelic losses at tumour suppressor gene loci during colorectal cancer progression. Nat. Med., 1: 902-909, 1995.
38. Fujii, H., Marsh, C., Cairns, P., Sidransky, D., and Gabrielson, E. Genetic divergence in the clonal evolution of breast cancer. Cancer Res., 56: 1493-1497, 1996.
39. Kibbelaar, R. E., Kok, F., Dreef, E. J., Kleiverda, J. K., Cornelisse, C. J., Raap, A. K., and Kluin, Ph. M. Statistical methods in interphase cytogenetics: an experimental approach. Cytometry, 14: 716-724, 1993.
40. Kuukasjärvi, T., Kononen, J., Helin, H., Holli, K., and Isola, J. Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy. J. Clin. Oncol., 14: 2584-2589, 1996.